Reactive arthritis after COVID-19.
Bo Langhoff HøngeMarie-Louise From HermansenMerete StorgaardPublished in: BMJ case reports (2021)
A previously healthy 53-year-old man was hospitalised for 12 days due to COVID-19 with shortness of breath. A few days after discharge from hospital, the patient developed fever and severe pain in several joints in the lower extremities. The pain was so severe that the patient was unable to stand on his feet. Synovial fluid from the right-side knee contained a high number of polynuclear cells and a few mononuclear cells. Microscopy, culture and PCR tests for bacterial infection were all negative. Furthermore, the patient tested negative for rheumatoid factor, anti-cyclic citrullinated peptide and human leukocyte antigen (HLA)-B27. Thus, the condition was compatible with reactive arthritis. The condition improved markedly after a few days' treatment with non-steroid anti-inflammatory drugs and prednisolone.
Keyphrases
- induced apoptosis
- coronavirus disease
- case report
- sars cov
- chronic pain
- cell cycle arrest
- rheumatoid arthritis
- endothelial cells
- pain management
- early onset
- healthcare
- cell death
- neuropathic pain
- total knee arthroplasty
- high resolution
- emergency department
- endoplasmic reticulum stress
- oxidative stress
- optical coherence tomography
- respiratory syndrome coronavirus
- spinal cord injury
- drug induced
- induced pluripotent stem cells
- single cell
- electronic health record
- pluripotent stem cells